PharmaLex Group expands to the Nordic Region following merger with Lindeq AS

The merger will further strengthen PharmaLex’s internationalization objective, allowing for greater global reach and local presence. Friedrichsdorf (Ts.) / Mannheim / Oslo, March 2016: The PharmaLex Group announces the merger with Lindeq AS (Norway) to further strengthen and support the growing local and international customer base in the Nordic Region. PharmaLex has reached another key milestone to drive internationalization, aiming for “Global Reach with Local Presence”. This merger is in line with the internationalization objective of the PharmaLex Group, which included the opening of a Swiss affiliate in January 2016.

Lindeq AS was founded in 2004 and is a medical consultancy specializing in drug safety and pharmacovigilance, cosmetovigilance, quality management and medical device vigilance. The services offered cover the entire product lifecycle – pre- and post-product launch. The company
is based in Oslo, Norway, with affiliates in Copenhagen, Denmark and Sofia, Bulgaria. Lindeq AS employs 21 people from various backgrounds.
“It was a logical step for Lindeq’s further evolvement to join the PharmaLex Group” explained Dr. Steen Lindequist, founder and chairman of the board. Solveig Blomvik, co-founder and CEO of Lindeq AS said “We are excited by the idea of building a new world-class champion in the area of scientific services, regulatory affairs and pharmacovigilance”. “We are very happy that we found Lindeq AS to have the same mindset and to be pursuing the same goal of internationalization by providing global presence with local reach to our customers” explained Dr. Thomas Dobmeyer, CEO PharmaLex. “In today’s increasingly complex healthcare market, it is a key value objective to offer high flexibility and broad experience. With Lindeq AS, we have found the ideal experts to expand our service portfolio to the Nordic region” added Dr. Tilo Netzer, CEO PharmaLex.

For further information, please contact:

Ms. Eva Keck
PharmaLex GmbH; Director Business Development Operations
eva.keck@pharmalex.com
+49 621 18 15 38 0
Harrlachweg 6; 68163 Mannheim
Germany